Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-08

Clinical Trial Update: Impact of Vitamin B12 Replacement on Epogen Dosing and Improvement of Quality of Life in Hemodialysis Patients [NA]

View source ↗

Summary

Completed clinical trial evaluated whether Vitamin B12 supplementation in hemodialysis patients reduces Epogen (epoetin alfa) dosing and improves quality of lif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epogen (epoetin alfa)
  • Vitamin B12 supplement (Cobalamin)

Snippet

Sponsor: Northwell Health | Conditions: Vitamin B12 Deficiency | NA | Status: COMPLETED | Results posted: 2014-09-08